Global Metformin Hydrochloride Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Global Metformin Hydrochloride Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

  • ID :
    SAC6706957
  • Published Date :
    Dec 2024
  • Number of Pages :
    300+

Year Considered

2019 to 2022: Historic Years

2023: Base Year

2024: Estimated Year

2025 to 2031: Projected Years

Product Description

Metformin, marketed under the trade name Glucophage among others, is the first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. It is also used in the treatment of polycystic ovary syndrome (PCOS). Limited evidence suggests metformin may prevent the cardiovascular disease and cancer complications of diabetes. It is not associated with weight gain. It is taken by mouth. Metformin is generally well tolerated. Common side effects include diarrhea, nausea and abdominal pain. It has a low risk of causing low blood sugar. High blood lactic acid level is a concern if the medication is prescribed inappropriately and in overly large doses. It should not be used in those with significant liver disease or kidney problems. While no clear harm comes from use during pregnancy, insulin is generally preferred for gestational diabetes. Metformin is in the biguanide class. It works by decreasing glucose production by the liver and increasing the insulin sensitivity of body tissues. The Metformin Hydrochloride market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global Metformin Hydrochloride market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the Metformin Hydrochloride Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in Metformin Hydrochloride market are: Mylan Pharma Bristol-Mayers Squibb Wanbury USV Merck & Co. Most important types of Metformin Hydrochloride products covered in this report are: Metformin HCL Metformin DC Most widely used downstream fields of Metformin Hydrochloride market covered in this report are: Metformin Hydrochloride Tablets Metformin Hydrochloride Extended-Release Tablets Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Get in Touch

We work with firms all across the US and Europe

Security Code:

Select Access

Trusted by

Testimonial

Get in Touch with Us